SCHEMBL9628124

SCHEMBL9628124

CCCC1=C(OC)C(=O)c2ccccc2C1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.61
ALDH1A1 P00352 10/20 0.61
KDM4E B2RXH2 8/20 0.61
LMNA P02545 7/20 0.61
HPGD P15428 7/20 0.61
POLB P06746 7/20 0.61
TDP1 Q9NUW8 6/20 0.61
SMN1; SMN2 Q16637 5/20 0.61
RAB9A P51151 4/20 0.61
CDC25A P30304 3/20 0.61
CDC25B P30305 3/20 0.61
MAP2K7 O14733 1/20 0.61
GMNN O75496 1/20 0.61
TP53 P04637 1/20 0.61
CYP1A2 P05177 1/20 0.61
CYP3A4 P08684 1/20 0.61
CYP2D6 P10635 1/20 0.61
CYP2C9 P11712 1/20 0.61
ALOX15 P16050 1/20 0.61
CYP2C19 P33261 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5810562 0.90 MAPT (0.68) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL9628157 0.88 ALOX5 (0.55) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL11660838 0.86 ALOX5 (0.57) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL10951203 0.86 ALOX5 (0.57) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL9628375 0.86 ALOX5 (0.57) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL9628254 0.85 MAPT (0.65) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL14307223 0.84 CDC25B (0.50) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL9627210 0.84 ELANE (0.50) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL9628126 0.84 CDC25B (0.49) MAPTALDH1A1KDM4ELMNAHPGD
SCHEMBL9627461 0.82 ALDH1A1 (0.41) MAPTALDH1A1KDM4ELMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155132-A Nonsteroidal antiinflammatory agents; treating psoriasis SYNTEX (U.S.A.) INC. (US) 1992-10-13 US disclosed
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 US disclosed
US-5091558-A Topical administeration SYNTEX (U.S.A.) INC. (US) 1992-02-25 US disclosed
US-5089657-A Topical antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-02-18 US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0282056-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 EP disclosed
EP-0150831-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS SYNTEX (U.S.A.) INC. (US) 1988-08-10 EP disclosed
US-4758587-A Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-07-19 US disclosed
EP-0150831-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1985-08-07 EP disclosed